Literature DB >> 19846853

Atypical hemolytic-uremic syndrome.

Marina Noris1, Giuseppe Remuzzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19846853     DOI： 10.1056/NEJMra0902814

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  404 in total

Review 1.  Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics.

Authors:  Tania N Petruzziello-Pellegrini; Philip A Marsden
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-07       Impact factor: 2.894

2.  Membrano-proliferative glomerulonephritis, atypical hemolytic uremic syndrome, and a new complement factor H mutation: report of a case.

Authors:  Elisa Gnappi; Marco Allinovi; Augusto Vaglio; Elena Bresin; Annalisa Sorosina; Francesco P Pilato; Landino Allegri; Lucio Manenti
Journal:  Pediatr Nephrol       Date:  2012-06-05       Impact factor: 3.714

3.  A case of atypical hemolytic uremic syndrome due to anti-factor H antibody in a patient presenting with a factor XII deficiency identified two novel mutations.

Authors:  Eiji Matsukuma; Yoshimitsu Gotoh; Yoshiyuki Kuroyanagi; Takuji Yamada; Mitsuji Iwasa; Satoshi Yamakawa; Takuhito Nagai; Nobuaki Takagi; Hiromu Mae; Kenji Iijima; Elena Bresin
Journal:  Clin Exp Nephrol       Date:  2011-01-27       Impact factor: 2.801

Review 4.  [Thrombophilic states in intensive care medicine].

Authors:  L Engelmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2011-10-28       Impact factor: 0.840

5.  Thrombotic microangiopathy: atypical HUS: current diagnostic and therapeutic approaches.

Authors:  Alejandra Rosales; Magdalena Riedl; Lothar B Zimmerhackl
Journal:  Nat Rev Nephrol       Date:  2010-09       Impact factor: 28.314

6.  A rare case of thrombotic microangiopathy triggered by acute pancreatitis.

Authors:  Kevin Singh; Ahmed Jamal Nadeem; Behzad Doratotaj
Journal:  BMJ Case Rep       Date:  2017-05-15

7.  Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab.

Authors:  Kaan Gulleroglu; Kibriya Fidan; Veysel S Hançer; Umut Bayrakci; Esra Baskin; Oguz Soylemezoglu
Journal:  Pediatr Nephrol       Date:  2013-02-07       Impact factor: 3.714

8.  Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation.

Authors:  Merve Postalcioglu; Haesook T Kim; Faruk Obut; Osman Arif Yilmam; Jiqiao Yang; Benjamin C Byun; Sophie Kupiec-Weglinski; Robert Soiffer; Jerome Ritz; Joseph H Antin; Edwin Alyea; John Koreth; Corey Cutler; Philippe Armand; Julie M Paik; David E Leaf; Vincent T Ho; Reza Abdi
Journal:  Biol Blood Marrow Transplant       Date:  2018-05-11       Impact factor: 5.742

Review 9.  Hemolytic uremic syndrome.

Authors:  Caterina Mele; Giuseppe Remuzzi; Marina Noris
Journal:  Semin Immunopathol       Date:  2014-02-14       Impact factor: 9.623

10.  Treatment of Atypical Hemolytic-Uremic Syndrome in the Era of Eculizumab.

Authors:  Rawaa Ebrahem; Salam Kadhem; Quoc Truong
Journal:  Cureus       Date:  2017-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.